Related Experiment Video

Updated: May 17, 2026

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)
08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)

Published on: January 7, 2018

Revisiting the diacylglycerol-induced insulin resistance hypothesis

F Amati1

  • 1Department of Physiology, University of Lausanne, 7 Bugnon, Lausanne, Switzerland. Francesca.amati@unil.ch

Obesity Reviews : an Official Journal of the International Association for the Study of Obesity
|October 31, 2012
PubMed

Insights

Obesity links to insulin resistance and type 2 diabetes. This review explores how diacylglycerols (DAGs), a type of lipid, may cause insulin resistance in muscle, despite conflicting study results.

Area of Science:

  • Metabolic research
  • Endocrinology
  • Molecular biology

Background:

  • Obesity is linked to skeletal muscle insulin resistance, a precursor to type 2 diabetes.
  • Lipotoxicity, inflammation, and oxidative stress are proposed mechanisms for obesity-induced insulin resistance.
  • Diacylglycerols (DAGs) are lipid metabolites implicated in lipotoxicity and insulin resistance.

Purpose of the Study:

  • To review the role of diacylglycerols (DAGs) in skeletal muscle insulin resistance.
  • To discuss hypotheses explaining contradictory findings on DAGs in human metabolism.
  • To highlight the potential of DAGs as signaling molecules.

Main Methods:

  • Literature review of current research on DAGs and insulin resistance.
  • Analysis of studies investigating DAGs in human skeletal muscle.
  • Synthesis of evidence regarding DAGs' role in metabolic signaling.

Main Results:

  • Conflicting results exist regarding the significance of DAG-induced insulin resistance in human skeletal muscle.
  • DAGs may function as critical signaling molecules in metabolic pathways.
  • Further research is needed to clarify the precise role of DAGs in human metabolism.

Conclusions:

  • Diacylglycerols (DAGs) are implicated in insulin resistance, but their exact role in human skeletal muscle remains debated.
  • Understanding DAG signaling is crucial for metabolic health and type 2 diabetes prevention.
  • Continued investigation into DAGs' function is essential for advancing metabolic research.

More Related Videos

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance09:48

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance

Published on: February 17, 2023

Related Concept Videos

Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...